Last updated: July 13, 2026

Application No. 18/726,571

Untitled Application

Unknown

Filed

Priority

Jan 05, 2022 — provisional 63/296,674 +1 more

Examiner

MOU, LIYUAN

Art Unit

Tech Center

Northwestern University

Assignee

Northwestern University

OA Round

1 (Non-Final)

This examiner grants 43% of cases after interview

— +56.4% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 112 resolved cases, 2023–2026

Examiner Intelligence

MOU, LIYUAN View full profile →

Grants 43% of resolved cases

Career Allowance Rate

48 granted / 112 resolved

-17.1% vs TC avg

Strong +56% interview lift

Without

With

+56.4%

Interview Lift

resolved cases with interview

Typical timeline

3y 0m

Avg Prosecution

66 currently pending

Career history

184

Total Applications

across all art units

Statute-Specific Performance

§101

0.3%

-39.7% vs TC avg

§103

40.0%

+0.0% vs TC avg

§102

0.7%

-39.3% vs TC avg

§112

2.2%

-37.8% vs TC avg

Black line = Tech Center average estimate • Based on career data from 112 resolved cases

Precedent Cases

Applications granted by this same examiner with similar technology

18/020,297

Patent 12662486

SOLID STATE FORMS OF AT-001 AND PROCESS FOR PREPARATION THEREOF

3y 4m to grant Granted Jun 23, 2026

19/043,910

Patent 12594276

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

1y 2m to grant Granted Apr 07, 2026

19/088,147

Patent 12589156

BENZIMIDAZOLE AND BENZIMIDAZOLONE BASED PROTAC COMPOUNDS FOR THE TARGETED DEGRADATION OF LEUCINE RICH REPEAT KINASE 2 (LRRK2)

1y 0m to grant Granted Mar 31, 2026

17/268,995

Patent 12576087

NOVEL ARYLOXYPIPERIDINE PYRAZOLE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS

5y 0m to grant Granted Mar 17, 2026

17/461,616

Patent 12551482

AURORA KINASE INHIBITORS

4y 5m to grant Granted Feb 17, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

43%

Grant Probability

99%

With Interview (+56.4%)

3y 0m

Median Time to Grant

Low

PTA Risk

Based on 112 resolved cases by this examiner. Grant probability derived from career allowance rate.